NCT05879627 2026-04-13To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid TumorsBio-Thera SolutionsPhase 1 Terminated93 enrolled
NCT07509684 2026-04-13A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid TumorsZhejiang Anglikang Pharmaceutical Co., Ltd.Phase 1/2 Not yet recruiting190 enrolled